Cargando…
Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
Introduction. The objectives of this systematic review were to evaluate the evidence for different CRC screening tests and to determine the most appropriate ages of initiation and cessation for CRC screening and the most appropriate screening intervals for selected CRC screening tests in people at a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002289/ https://www.ncbi.nlm.nih.gov/pubmed/27597935 http://dx.doi.org/10.1155/2016/2878149 |
_version_ | 1782450546546835456 |
---|---|
author | Tinmouth, Jill Vella, Emily T. Baxter, Nancy N. Dubé, Catherine Gould, Michael Hey, Amanda Ismaila, Nofisat McCurdy, Bronwen R. Paszat, Lawrence |
author_facet | Tinmouth, Jill Vella, Emily T. Baxter, Nancy N. Dubé, Catherine Gould, Michael Hey, Amanda Ismaila, Nofisat McCurdy, Bronwen R. Paszat, Lawrence |
author_sort | Tinmouth, Jill |
collection | PubMed |
description | Introduction. The objectives of this systematic review were to evaluate the evidence for different CRC screening tests and to determine the most appropriate ages of initiation and cessation for CRC screening and the most appropriate screening intervals for selected CRC screening tests in people at average risk for CRC. Methods. Electronic databases were searched for studies that addressed the research objectives. Meta-analyses were conducted with clinically homogenous trials. A working group reviewed the evidence to develop conclusions. Results. Thirty RCTs and 29 observational studies were included. Flexible sigmoidoscopy (FS) prevented CRC and led to the largest reduction in CRC mortality with a smaller but significant reduction in CRC mortality with the use of guaiac fecal occult blood tests (gFOBTs). There was insufficient or low quality evidence to support the use of other screening tests, including colonoscopy, as well as changing the ages of initiation and cessation for CRC screening with gFOBTs in Ontario. Either annual or biennial screening using gFOBT reduces CRC-related mortality. Conclusion. The evidentiary base supports the use of FS or FOBT (either annual or biennial) to screen patients at average risk for CRC. This work will guide the development of the provincial CRC screening program. |
format | Online Article Text |
id | pubmed-5002289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-50022892016-09-05 Colorectal Cancer Screening in Average Risk Populations: Evidence Summary Tinmouth, Jill Vella, Emily T. Baxter, Nancy N. Dubé, Catherine Gould, Michael Hey, Amanda Ismaila, Nofisat McCurdy, Bronwen R. Paszat, Lawrence Can J Gastroenterol Hepatol Review Article Introduction. The objectives of this systematic review were to evaluate the evidence for different CRC screening tests and to determine the most appropriate ages of initiation and cessation for CRC screening and the most appropriate screening intervals for selected CRC screening tests in people at average risk for CRC. Methods. Electronic databases were searched for studies that addressed the research objectives. Meta-analyses were conducted with clinically homogenous trials. A working group reviewed the evidence to develop conclusions. Results. Thirty RCTs and 29 observational studies were included. Flexible sigmoidoscopy (FS) prevented CRC and led to the largest reduction in CRC mortality with a smaller but significant reduction in CRC mortality with the use of guaiac fecal occult blood tests (gFOBTs). There was insufficient or low quality evidence to support the use of other screening tests, including colonoscopy, as well as changing the ages of initiation and cessation for CRC screening with gFOBTs in Ontario. Either annual or biennial screening using gFOBT reduces CRC-related mortality. Conclusion. The evidentiary base supports the use of FS or FOBT (either annual or biennial) to screen patients at average risk for CRC. This work will guide the development of the provincial CRC screening program. Hindawi Publishing Corporation 2016 2016-08-14 /pmc/articles/PMC5002289/ /pubmed/27597935 http://dx.doi.org/10.1155/2016/2878149 Text en Copyright © 2016 Jill Tinmouth et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Tinmouth, Jill Vella, Emily T. Baxter, Nancy N. Dubé, Catherine Gould, Michael Hey, Amanda Ismaila, Nofisat McCurdy, Bronwen R. Paszat, Lawrence Colorectal Cancer Screening in Average Risk Populations: Evidence Summary |
title | Colorectal Cancer Screening in Average Risk Populations: Evidence Summary |
title_full | Colorectal Cancer Screening in Average Risk Populations: Evidence Summary |
title_fullStr | Colorectal Cancer Screening in Average Risk Populations: Evidence Summary |
title_full_unstemmed | Colorectal Cancer Screening in Average Risk Populations: Evidence Summary |
title_short | Colorectal Cancer Screening in Average Risk Populations: Evidence Summary |
title_sort | colorectal cancer screening in average risk populations: evidence summary |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002289/ https://www.ncbi.nlm.nih.gov/pubmed/27597935 http://dx.doi.org/10.1155/2016/2878149 |
work_keys_str_mv | AT tinmouthjill colorectalcancerscreeninginaverageriskpopulationsevidencesummary AT vellaemilyt colorectalcancerscreeninginaverageriskpopulationsevidencesummary AT baxternancyn colorectalcancerscreeninginaverageriskpopulationsevidencesummary AT dubecatherine colorectalcancerscreeninginaverageriskpopulationsevidencesummary AT gouldmichael colorectalcancerscreeninginaverageriskpopulationsevidencesummary AT heyamanda colorectalcancerscreeninginaverageriskpopulationsevidencesummary AT ismailanofisat colorectalcancerscreeninginaverageriskpopulationsevidencesummary AT mccurdybronwenr colorectalcancerscreeninginaverageriskpopulationsevidencesummary AT paszatlawrence colorectalcancerscreeninginaverageriskpopulationsevidencesummary |